Quantcast

Industry news that matters to you.  Learn more

Researchers Develop Urine Test for Heart Disease

Scientists at the University of Glasgow have developed a simple test to detect coronary artery disease by analysing urine samples.

The test looks for particular protein expressions, or biomarkers, associated with the disease and has been shown to have an accuracy rate of almost 90 per cent.

Metabolon Awarded US Patent for Metabolic Biomarkers of Efficacy of Peroxisome Proliferator Activated Receptor (PPAR) Affecting Drugs

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled “Biomarkers of Metabolic Responses to Hepatic Drugs”. The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.

Lilly to Close Singapore Discovery Center

Eli Lilly will be closing the Lilly Singapore Centre for Drug Discovery by the end of the year, according to an email sent out this morning by Jonathon Sedgwick, Managing Director & Chief Scientific Officer, Lilly Singapore Centre for Drug Discovery (LSCDD).

Discovery and Validation of 13 Diabetes Biomarkers to be Commercialized

After three years of collaborative research involving patients from The Busselton Health Study, drug discovery company Proteomics International announced the identification and analytical validation of 13 protein biomarkers for a significant complication of diabetes – diabetic nephropathy (kidney disease). In a presentation at the Human Proteome Organisation’s World Congress in Sydney, Australia, Dr Richard Lipscombe, Managing Director of Proteomics International, revealed the findings that could benefit many of the 250 million people worldwide who have diabetes.

New Clue to Diabetic Heart Disease Discovered

Scientists from King’s College London have identified a molecule that could help predict type 2 diabetes and identify diabetics that are most vulnerable to heart and circulatory disease.